4 min read
Plenary Session Presentation: Putting Science First in Rare Disease Studies
Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...
1 min read
Assembling the Adaptive Puzzle is Challenging
“Multiple factors drive the success of an adaptive design trial. Often, the most brilliant, innovative adaptive model is not enough to reach study goals. One must consider the key issues to be faced within study implementation, conduct, and regulatory placement. Veristat takes on a comprehensive and collaborative approach to study design, while it is also able to manage the implementation and study conduct with scientific integrity, client focus and industry leading expertise.”- John Balser, President of Veristat
Veristat Insights Help Bring the Puzzle Together
Assembling the pieces for a successful adaptive clinical trial is a challenging endeavor. Planning for and executing upon the dynamic steps required to create a successful trial requires the application of intellect, experience, and a pragmatic approach. Through 20 years of designing, implementing, and conducting on over 650 clinical studies across a broad spectrum of therapeutic areas, Veristat provides expert guidance on many adaptive trials. Whether you are focused on oncology, or rare disease, Veristat can lend a hand in solving the puzzle by identifying and helping you answer critical questions that aid in determining if an adaptive design is right for you and how to deliver on the full potential of an adaptive trial.
How We Can Help with Your Adaptive Trial Planning Efforts:
Collaborative Trial Design:
Data Collection & Analysis:
Recommendations & Parameter Adjustments:
For more information on Veristat, and our services, please contact info@veristat.com.
4 min read
Mar 22, 2024 Veristat Events
Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...
1 min read
Mar 19, 2024 Veristat Events
Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024
With nearly 30 years of experience in clinical trial...